WMSA
CALA

Weiss Multi-Strategy Advisers’s Calithera Biosciences, Inc CALA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-500
Closed -$149K – 646
2017
Q2 		$149K Buy
+500
New +$134K 0.01% 499

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CALA Position: Q3 2017 in Review

Weiss Multi-Strategy Advisers sold out of Calithera Biosciences, Inc (CALA) in Q3 2017, closing a stake of 500 shares — an estimated $149K sold.

Weiss Multi-Strategy Advisers first reported a position in CALA in Q2 2017 and held it in 1 quarter. The position peaked at $149K in Q2 2017. 91 funds tracked by Wall St. Rank hold CALA as of Q3 2017.

  • Weiss Multi-Strategy Advisers reported no remaining Calithera Biosciences, Inc position as of Q3 2017 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 500 Calithera Biosciences, Inc shares in Q3 2017, an estimated $149K.
  • Weiss Multi-Strategy Advisers first reported a position in Calithera Biosciences, Inc in Q2 2017 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Calithera Biosciences, Inc position peaked at $149K in Q2 2017.
  • 91 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.